XETRA : AMG.DE

Amgen Inc.

$330.25 EUR

$6.45 (1.99%)

Volume
213
Average Volume
354
Market Capitalization
$178.24B
P/E Ratio
25.97
Dividend Yield
2.61%
Price Target
Year High
$333.00
Year Low
$230.00
Day High
—
Day Low
—
Payout Ratio
$0.67
Current Ratio
$1.26
Company Overview

XETRA

Robert A. Bradway

Drug Manufacturers - General

Healthcare

AMG.DE

31500

US

EUR

https://www.amgen.com

805 447 1000

031162100

N/A

Liquidity Metrics

6.24

1.26

1.01

0.48

0.67

Sales & Valuation

$36.75B

5.45

22.10

23.61

15.92

Profitability

$14.23

$7.71B

20.95%

24.40%

89.41%

8.43%

P/E Metrics

25.97

0.84

0.84

Analyst Price Target & Rating

Neutral

3/5

38 Analysts

%

Financial Health Scores

1.98

8/9

$6.5B

$92.15B

$83B

$11.95B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Casey Capparelli Executive Director of Investor Relations
Esteban Santos Executive Vice President of Operations
Jonathan Graham Executive Vice President, General Counsel & Secretary
Sam Guhan Senior Vice President of Global Engineering
Scott Skellenger Senior Vice President & Chief Information Officer
David Reese Executive Vice President
Matthew C. Busch Chief Accounting Officer & Vice President of Finance
Sean Bruich SVP & Chief Technology Officer
Nancy A. Grygiel Senior Vice President of Worldwide Compliance & Business Ethics and Chief Compliance Officer
James E. Bradner EVP of Research & Development, Artificial Intelligence and Data
Peter H. Griffith Executive Vice President & Chief Financial Officer
Robert A. Bradway Chairman & CEO
Howard Y. Chang Senior Vice President of Global Research & Chief Scientific Officer
Jasper van Grunsven Senior Vice President of Rare Disease, Global Commercial Capabilities & Innovation
Som Chattopadhyay Senior Vice President of Global Business Solutions & National Executive
Andrew H. Martin Senior VP & GM of U.S. Business Operations
Murdo Gordon Executive Vice President of Global Markets and Policy
Poll Results

No votes yet today — be the first to share your view!

About Amgen Inc. (XETRA:AMG.DE) Stock

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, operates globally as a biopharmaceutical company focused on discovering, developing, manufacturing, and delivering human therapeutics. The firm concentrates its research and development efforts on critical therapeutic areas such as inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Its extensive product portfolio includes a range of impactful medicines. Examples feature Enbrel for autoimmune conditions like psoriasis and arthritis, Neulasta to mitigate infection risk in cancer patients with low white blood cell counts, Prolia for postmenopausal osteoporosis, and Repatha to decrease the likelihood of heart attack, stroke, and coronary revascularization. Other ke ... y offerings include Xgeva, Otezla, Aranesp, and KYPROLIS, among numerous additional treatments like Nplate, Vectibix, and Aimovig. Amgen distributes its products through pharmaceutical wholesalers and direct-to-consumer channels, serving a wide array of healthcare providers, including physicians, clinics, hospitals, and pharmacies. The company actively pursues strategic collaborations to advance its pipeline. Notable partnerships include an agreement with Verastem, Inc., among others, to investigate VS-6766 in combination with lumakrastm (Sotorasib) for KRAS G12C-mutant non-small cell lung cancer. It also works with Kyowa Kirin Co., Ltd. to develop KHK4083 for atopic dermatitis and other autoimmune diseases, and engages in research alliances with Neumora Therapeutics, Inc. and Plexium, Inc.

Frequently Asked Questions

What is the current Amgen Inc. (AMG.DE) stock price?

Amgen Inc.(XETRA:AMG.DE) stock price is $330.25 in the last trading session. During the trading session, AMG.DE stock reached the peak price of $333 while $230 was the lowest point it dropped to. The percentage change in AMG.DE stock occurred in the recent session was 1.99% while the dollar amount for the price change in AMG.DE stock was $6.45.

AMG.DE's industry and sector of operation?

The XETRA listed AMG.DE is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector.

Who are the executives of AMG.DE?

Casey Capparelli | Executive Director of Investor Relations
Esteban Santos | Executive Vice President of Operations
Jonathan Graham | Executive Vice President, General Counsel & Secretary
Sam Guhan | Senior Vice President of Global Engineering
Scott Skellenger | Senior Vice President & Chief Information Officer

How many employees does AMG.DE have?

Number of AMG.DE employees currently stands at 31500. AMG.DE operates from One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US.

Link for AMG.DE official website?

Official Website of AMG.DE is: https://www.amgen.com

How do I contact AMG.DE?

AMG.DE could be contacted at phone #805 447 1000 and can also be accessed through its website. AMG.DE operates from One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US.

How many shares of AMG.DE are traded daily?

The average number of AMG.DE shares traded daily for last 3 months was 354.

What is the market cap of AMG.DE currently?

The market value of AMG.DE currently stands at $178.24B with its latest stock price at $330.25